Invention Grant
![Methods of treating cancer with a thieno[3,2-C]pyridine](/docs/US/2013-11-26/US08592589B2/abs.jpg.600x600.jpg)
- Patent Title: Methods of treating cancer with a thieno[3,2-C]pyridine
- Patent Title (中): 用噻吩并[3,2-C]吡啶治疗癌症的方法
-
Application No.: US13717246Application Date: 2012-12-17
-
Publication No.: US08592589B2Publication Date: 2013-11-26
- Inventor: Geoff G. Z. Zhang , Paul J. Brackemeyer , Ahmad Y. Sheikh
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Susan L. Steele
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D513/02
![Methods of treating cancer with a thieno[3,2-C]pyridine](/abs-image/US/2013/11/26/US08592589B2/abs.jpg.150x150.jpg)
Abstract:
N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N′-(3-fluorophenyl)urea free base and crystallines form thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
Public/Granted literature
- US20130136804A1 Crystal Forms of Kinase Inhibitors Public/Granted day:2013-05-30
Information query
